The role of angiotensin II and plasminogen activator inhibitor-1 in progressive glomerulosclerosis

Lewis, 1993, The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy, N Engl J Med, 329, 1456, 10.1056/NEJM199311113292004 Cattran, 1994, Long-term benefits of angiotensin-converting enzyme inhibitor therapy in patients with severe immunoglobulin A nephropathy: A comparison to patients receiving treatment with other antihypertensive agents and to patients receiving no therapy, Am J Kidney Dis, 23, 247, 10.1016/S0272-6386(12)80980-2 Maschio, 1996, Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency, N Engl J Med, 334, 939, 10.1056/NEJM199604113341502 Kasiske, 1993, Effect of antihypertensive therapy on the kidney in patients with diabetes: A meta-regression analysis, Ann Intern Med, 118, 129, 10.7326/0003-4819-118-2-199301150-00009 Tanaka, 1994, Angiotensin converting enzyme inhibitor modulates glomerular function and structure by distinct mechanisms, Kidney Int, 45, 537, 10.1038/ki.1994.69 Oikawa, 1997, Modulation of plasminogen activator inhibitor-1 in vivo: A new mechanism for the anti-fibrotic effect of renin-angiotensin inhibition, Kidney Int, 51, 164, 10.1038/ki.1997.20 Moulder, 1996, Angiotensin II receptor antagonists in the prevention of radiation nephropathy, Radiat Res, 146, 106, 10.2307/3579403 Anderson, 1985, Control of glomerular hypertension limits glomerular injury in rats with reduced renal mass, J Clin Invest, 76, 612, 10.1172/JCI112013 Hostetter, 1981, Hyperfiltration in remnant nephrons: A potentially adverse response to renal ablation, Am J Physiol, 241, F85 Fogo, 1988, Serial micropuncture analysis of glomerular function in two rat models of glomerular sclerosis, J Clin Invest, 82, 322, 10.1172/JCI113590 Anderson, 1986, Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat, J Clin Invest, 77, 1993, 10.1172/JCI112528 Brenner, 1982, Dietary protein intake and the progressive nature of kidney disease: The role of hemodynamically mediated glomerular injury in the pathogenesis of progressive glomerular sclerosis in aging, renal ablation, and intrinsic renal disease, N Engl J Med, 307, 652, 10.1056/NEJM198209093071104 Yoshida, 1988, Serial micropuncture analysis of single nephron function in subtotal renal ablation, Kidney Int, 33, 855, 10.1038/ki.1988.77 Yoshida, 1989, Glomerular hemodynamic changes vs. hypertrophy in experimental glomerular sclerosis, Kidney Int, 35, 654, 10.1038/ki.1989.35 Yoshida, 1989, Effects of antihypertensive drugs on glomerular morphology, Kidney Int, 36, 626, 10.1038/ki.1989.239 Fogo, 1999, Glomerular hypertrophy in minimal change disease predicts subsequent progression to focal glomerular sclerosis, Kidney Int, 38, 115, 10.1038/ki.1990.175 Nyberg, 1994, Glomerular volume and renal function in children with different types of the nephrotic syndrome, Pediatr Nephrol, 8, 285, 10.1007/BF00866336 Kim, 1998, Glomerular growth in childhood focal segmental glomerulosclerosis, Pediatr Nephrol, 12, 108, 10.1007/s004670050415 Danilewicz, 1996, Minimal change disease and idiopathic focal segmental glomerulosclerosis in adults: A quantitative study, Pol J Pathol, 47, 209 Suzuki, 1994, A quantitative analysis of the glomeruli in focal segmental glomerulosclerosis, Pediatr Nephrol, 8, 416, 10.1007/BF00856517 Homma, 1990, Angiotensin II induces hypertrophy and stimulates collagen production in cultured rat glomerular mesangial cell, Clin Res, 38, 358A Wolf, 1992, Angiotensin II stimulates the proliferation and biosynthesis of type I collagen in cultured murine mesangial cells, Am J Pathol, 140, 95 Matsusaka, 1996, Angiotensin in progressive renal diseases: Theory and practice, J Am Soc Nephrol, 7, 2025, 10.1681/ASN.V7102025 Harrison-Bernard, 1997, Immunohistochemical localization of ANG II AT1 receptor in adult rat kidney using a monoclonal antibody, Am J Physiol, 273, F170 Ardaillou, 1999, Angiotensin II receptors, J Am Soc Nephrol, 10, S30 Allen, 1999, Localization of angiotensin AT1 and AT2 receptors, J Am Soc Nephrol, 10, S23 Yamada, 1996, Angiotensin II type 2 receptor mediates programmed cell death, Proc Natl Acad Sci U S A, 93, 156, 10.1073/pnas.93.1.156 Ichiki, 1995, Effects on blood pressure and exploratory behaviour of mice lacking angiotensin II type-2 receptor, Nature, 377, 748, 10.1038/377748a0 Ma, 1990, Accelerated fibrosis and collagen deposition develop in the renal interstitium of angiotensin type 2 receptor null mutant mice during ureteral obstruction, Kidney Int, 53, 937, 10.1111/j.1523-1755.1998.00893.x Ohkubo, 1997, Angiotensin type 2 receptors are reexpressed by cardiac fibroblasts from failing myopathic hamster hearts and inhibit cell growth and fibrillar collagen metabolism, Circulation, 96, 3954, 10.1161/01.CIR.96.11.3954 Sharma, 1998, Documentation of angiotensin II receptors in glomerular epithelial cells, Am J Physiol, 274, F623 Coleman, 1998, Autoradiographic identification of kidney angiotensin IV binding sites and angiotensin IV-induced renal cortical blood flow changes in rats, Peptides, 19, 269, 10.1016/S0196-9781(97)00291-X Chansel, 1998, Characterization of angiotensin IV-degrading enzymes and receptors on rat mesangial cells, Am J Physiol, 275, F535 Ikoma, 1991, Cause of variable therapeutic efficacy of angiotensin converting enzyme inhibitor on glomerular lesions, Kidney Int, 40, 195, 10.1038/ki.1991.200 Nakamura, 1999, Regression of established glomerulosclerosis by high dose angiotensin type 1 receptor antagonist (AIIRA) is linked to inhibition of plasminogen activator inhibitor-1 (PAI-1), J Am Soc Nephrol, 10, 665A Marinides, 1990, Enalapril and low protein reverse chronic puromycin aminonucleoside nephropathy, Kidney Int, 37, 749, 10.1038/ki.1990.42 Carome, 1993, Human glomeruli express tissue inhibitor of metalloproteinase-1 (TIMP-1) mRNA and TIMP-2 protein and mRNA, Am J Physiol, 264, F923 Johnson, 1993, Role of platelet-derived growth factor in glomerular disease, J Am Soc Nephrol, 4, 119, 10.1681/ASN.V42119 Wolf, 1998, Angiotensin II is involved in the progression of renal disease: Importance of non-hemodynamic mechanisms, Nephrologie, 19, 451 Ketteler, 1995, Transforming growth factor-β and angiotensin II: The missing link from glomerular hyperfiltration to glomerulosclerosis?, Annu Rev Physiol, 57, 279, 10.1146/annurev.ph.57.030195.001431 Brown, 1996, The renin-angiotensin and fibrinolytic systems: Co-conspirators in the pathogenesis of ischemic cardiovascular disease, Trends Cardiovasc Med, 6, 239, 10.1016/S1050-1738(96)00091-6 Vassalli, 1991, The plasminogen activator/plasmin system, J Clin Invest, 88, 1067, 10.1172/JCI115405 Becquemont, 1994, Expression of plasminogen/plasmin receptors on human glomerular epithelial cells, Am J Physiol, 267, F303 Kanalas, 1995, Analysis of the plasminogen system on rat glomerular epithelial cells, Exp Cell Res, 218, 561, 10.1006/excr.1995.1191 Schleef, 1989, Bleeding diathesis due to decreased functional activity of type 1 plasminogen activator inhibitor, J Clin Invest, 83, 1747, 10.1172/JCI114076 Dieval, 1991, A lifelong bleeding disorder associated with a deficiency of plasminogen activator inhibitor type 1, Blood, 77, 528, 10.1182/blood.V77.3.528.528 Fay, 1992, Brief report: Complete deficiency of plasminogen-activator inhibitor type 1 due to a frame-shift mutation, N Engl J Med, 327, 1729, 10.1056/NEJM199212103272406 Keeton, 1993, Cellular localization of type 1 plasminogen activator inhibitor messenger RNA and protein in murine renal tissue, Am J Pathol, 142, 59 Erickson, 1990, Development of venous occlusions in mice transgenic for the plasminogen activator inhibitor-1 gene, Nature, 346, 74, 10.1038/346074a0 Hamsten, 1987, Plasminogen activator inhibitor in plasma: Risk factor for recurrent myocardial infarction, Lancet, 2, 3, 10.1016/S0140-6736(87)93050-9 Kerins, 1995, Angiotensin induction of PAI-1 expression in endothelial cells is mediated by the hexapeptide angiotensin IV, J Clin Invest, 96, 2515, 10.1172/JCI118312 Vaughan, 1995, Angiotensin II regulates the expression of plasminogen activator inhibitor-1 in cultured endothelial cells, J Clin Invest, 95, 995, 10.1172/JCI117809 Feener, 1995, Angiotensin II induces plasminogen activator inhibitor-1 and -2 expression in vascular endothelial and smooth muscle cells, J Clin Invest, 95, 1353, 10.1172/JCI117786 van Leeuwen, 1994, Angiotensin II increases plasminogen activator inhibitor type 1 and tissue-type plasminogen activator messenger RNA in cultured rat aortic smooth muscle cells, Circulation, 90, 362, 10.1161/01.CIR.90.1.362 Kagami, 1997, Dual effects of angiotensin II on the plasminogen/plasmin system in rat mesangial cells, Kidney Int, 51, 664, 10.1038/ki.1997.96 Hamdan, 1996, Angiotensin-converting enzyme inhibition suppresses plasminogen activator inhibitor-1 expression in the neointima of balloon-injured rat aorta, Circulation, 93, 1073, 10.1161/01.CIR.93.6.1073 Kitching, 1996, Glomerulonephritis in mice with genetic deficiencies of the plasminogen/plasmin system, J Am Soc Nephrol, 7, 1738A Kitching, 1997, Plasminogen and plasminogen activators protect against renal injury in crescentic glomerulonephritis, J Exp Med, 185, 963, 10.1084/jem.185.5.963 Chant, 1994, Plasminogen activator inhibitor activity in diarrhoea-associated haemolytic uraemic syndrome, Q J Med, 87, 737, 10.1093/oxfordjournals.qjmed.a068891 Xu, 1996, Different expression of the plasminogen activation system in renal thrombotic microangiopathy and the normal human kidney, Kidney Int, 50, 2011, 10.1038/ki.1996.523 Vaughan, 1997, The renin-angiotensin system and fibrinolysis, Am J Cardiol, 79, 12, 10.1016/S0002-9149(97)00124-0 Ridker, 1993, Stimulation of plasminogen activator inhibitor in vivo by infusion of angiotensin II. Evidence of a potential interaction between the renin-angiotensin system and fibrinolytic function, Circulation, 87, 1969, 10.1161/01.CIR.87.6.1969 Vaughan, 1997, Effects of ramipril on plasma fibrinolytic balance in patients with acute anterior myocardial infarction, Circulation, 96, 442, 10.1161/01.CIR.96.2.442 Brown, 1995, Plasminogen activator inhibitor antigen is increased in hypertensive African Americans with the ACE D allele, Circulation, 92, I-552A Samani, 1996, A meta-analysis of the association of the deletion allele of the angiotensin-converting enzyme gene with myocardial infarction, Circulation, 94, 708, 10.1161/01.CIR.94.4.708 Eriksson, 1995, Allele-specific increase in basal transcription of the plasminogen-activator inhibitor 1 gene is associated with myocardial infarction, Proc Natl Acad Sci U S A, 92, 1851, 10.1073/pnas.92.6.1851 Kimura, 1998, Polymorphisms of angiotensin converting enzyme and plasminogen activator inhibitor-1 genes in diabetes and macroangiopathy, Kidney Int, 54, 1659, 10.1046/j.1523-1755.1998.00139.x Vaughan, 1997, Endothelial function, fibrinolysis, and angiotensin-converting enzyme inhibition, Clin Cardiol, 20, S1134 Ritz, 1993, Pathophysiology of hypertensive renal damage, Am J Hypertens, 6, S241, 10.1093/ajh/6.7.241S Feener, 1997, Vascular dysfunction in diabetes mellitus, Lancet, 350, SI9, 10.1016/S0140-6736(97)90022-2 Sibai, 1994, Curr Opin Nephrol Hypertens, 3, 436, 10.1097/00041552-199407000-00010 Nangaku, 1998, A new model of renal microvascular injury, Curr Opin Nephrol Hypertens, 7, 457, 10.1097/00041552-199807000-00018 Lemstrom, 1995, Molecular mechanisms of chronic renal allograft rejection, Kidney Int, 52, S2 Gibbons, 1997, Endothelial function as a determinant of vascular function and structure: A new therapeutic target, Am J Cardiol, 79, 3, 10.1016/S0002-9149(97)00122-7 Zoja, 1992, Renal protective effect of angiotensin-converting enzyme inhibition in aging rats, Am J Med, 92, S60, 10.1016/0002-9343(92)90149-6 Heudes, 1994, Effect of chronic ANG-I-converting enzyme inhibition on aging processes. I. Kidney structure and function, Am J Physiol, 266, R1038 Michel, 1994, Effect of chronic ANG-I-converting enzyme inhibition on aging processes. II. Large arteries, Am J Physiol, 267, R124 Ma, 1999, Regression of glomerulosclerosis in aging by angiotensin II type 1 receptor antagonist (AIIRA) is linked to inhibition of plasminogen activator inhibitor-1 (PAI-1), J Am Soc Nephrol, 10, 576A Nakamura, 1998, Plasminogen activator inhibitor-1 (PAI-1) is induced directly by angiotensin type 1 receptor in vivo, J Am Soc Nephrol, 9, 523A